Lynn W.W. Tsang

538 total citations
10 papers, 427 citations indexed

About

Lynn W.W. Tsang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lynn W.W. Tsang has authored 10 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lynn W.W. Tsang's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Diabetes Treatment and Management (3 papers) and Diabetes Management and Research (3 papers). Lynn W.W. Tsang is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Diabetes Treatment and Management (3 papers) and Diabetes Management and Research (3 papers). Lynn W.W. Tsang collaborates with scholars based in China and Hong Kong. Lynn W.W. Tsang's co-authors include Clive S. Cockram, Juliana C.N. Chan, Chun‐Chung Chow, Gary T.C. Ko, Ming Wai Yeung, G. T. C. Ko, June K.Y. Li, Gary Ko, Julia Critchley and V.T.F. Yeung and has published in prestigious journals such as Diabetes Care, Atherosclerosis and Diabetic Medicine.

In The Last Decade

Lynn W.W. Tsang

10 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn W.W. Tsang China 8 280 83 83 68 58 10 427
A. Gokcel Türkiye 8 141 0.5× 119 1.4× 34 0.4× 70 1.0× 31 0.5× 8 394
Su Shen China 9 204 0.7× 113 1.4× 98 1.2× 42 0.6× 9 0.2× 23 432
Cindy Meun Netherlands 12 220 0.8× 24 0.3× 36 0.4× 25 0.4× 64 1.1× 17 552
Tejpal Purewal United Kingdom 10 123 0.4× 89 1.1× 23 0.3× 68 1.0× 11 0.2× 16 287
Ramin Rezaeianzadeh Canada 6 196 0.7× 72 0.9× 63 0.8× 63 0.9× 4 0.1× 14 356
V. Baskar United Kingdom 7 191 0.7× 58 0.7× 62 0.7× 26 0.4× 41 0.7× 20 286
Dominique Ballaux Belgium 9 122 0.4× 78 0.9× 32 0.4× 104 1.5× 40 0.7× 17 307
Belén Vega‐Piñero Spain 11 85 0.3× 84 1.0× 43 0.5× 78 1.1× 15 0.3× 22 342
María José Tapia Spain 10 226 0.8× 69 0.8× 23 0.3× 104 1.5× 5 0.1× 27 386
Umesh Dashora United Kingdom 11 344 1.2× 153 1.8× 77 0.9× 34 0.5× 33 0.6× 52 547

Countries citing papers authored by Lynn W.W. Tsang

Since Specialization
Citations

This map shows the geographic impact of Lynn W.W. Tsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn W.W. Tsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn W.W. Tsang more than expected).

Fields of papers citing papers by Lynn W.W. Tsang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn W.W. Tsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn W.W. Tsang. The network helps show where Lynn W.W. Tsang may publish in the future.

Co-authorship network of co-authors of Lynn W.W. Tsang

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn W.W. Tsang. A scholar is included among the top collaborators of Lynn W.W. Tsang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn W.W. Tsang. Lynn W.W. Tsang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ko, Gary T.C., Juliana C.N. Chan, Ming Wai Yeung, et al.. (2001). A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese. European Journal of Epidemiology. 17(3). 289–295. 56 indexed citations
2.
Ko, Gary, Juliana C.N. Chan, Lynn W.W. Tsang, Julia Critchley, & Clive S. Cockram. (2001). Smoking and diabetes in Chinese men. Postgraduate Medical Journal. 77(906). 240–243. 34 indexed citations
3.
Ko, Gary T.C., et al.. (1999). Glucose Intolerance and Other Cardiovascular Risk Factors in Chinese Women with a History of Gestational Diabetes Mellitus. Australian and New Zealand Journal of Obstetrics and Gynaecology. 39(4). 478–483. 44 indexed citations
4.
Ko, G. T. C., et al.. (1999). Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabetic Medicine. 16(8). 670–674. 84 indexed citations
5.
Ko, Gary T.C., Tony W.L. Mak, Ming Wai Yeung, et al.. (1998). Short‐term Efficacy and Tolerability of Combination Therapy with Lovastatin and Acipimox in Chinese Patients with Type 2 Diabetes Mellitus and Mixed Dyslipidemia. The Journal of Clinical Pharmacology. 38(10). 912–917. 4 indexed citations
6.
Ko, Gary T.C., Juliana C.N. Chan, Ming Wai Yeung, et al.. (1998). Combined Use of a Fasting Plasma Glucose Concentration and HbA1c or Fructosamine Predicts the Likelihood of Having Diabetes in High-Risk Subjects. Diabetes Care. 21(8). 1221–1225. 92 indexed citations
8.
Ko, Gary T.C., Ming Wai Yeung, Juliana C.N. Chan, et al.. (1997). Plasma fibrinogen concentration in a Chinese population. Atherosclerosis. 131(2). 211–217. 16 indexed citations
9.
Ko, Gary T.C., Ming Wai Yeung, Lynn W.W. Tsang, Chun‐Chung Chow, & Clive S. Cockram. (1995). Comparison of the effects of gemfibrozil (600 mg twice daily and 900 mg once daily) on lipid and glucose levels in chinese patients with non—insulin-dependent diabetes mellitus. Current Therapeutic Research. 56(10). 1033–1040. 2 indexed citations
10.
Chow, Chun‐Chung, et al.. (1995). Comparison of Insulin With or Without Continuation of Oral Hypoglycemic Agents in the Treatment of Secondary Failure in NIDDM Patients. Diabetes Care. 18(3). 307–314. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026